Skip to main content
. 2022 Oct 10;7(19):e160607. doi: 10.1172/jci.insight.160607

Figure 1. Enrichment curves for VLDL1, VLDL2, IDL, and LDL apoB100 in patients with APOC3 LOF variants and nonvariant carriers.

Figure 1

Tracer/tracee ratios (data points are means and vertical lines represent standard deviations) are presented for apoB100 in each lipoprotein density range. Time in hours is from tracer administration. Solid line refers to the mean of the model fits.